Low molecular weight heparin (enoxaparin) in the management of unstable angina: the ESSENCE study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events.
Fox
K A
KA
Cardiovascular Research Unit, University of Edinburgh, Royal Infirmary of Edinburgh, Edinburgh EH3 9YW, UK.
D000328:Adult; D000368:Aged; D000789:Angina, Unstable / Q000188:drug therapy*; D000925:Anticoagulants / Q000627:therapeutic use*; D018572:Disease-Free Survival; D004311:Double-Blind Method; D017984:Enoxaparin / Q000627:therapeutic use*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012008:Recurrence
D000925:Anticoagulants; D017984:Enoxaparin; D005343:Fibrinolytic Agents